In 2024, I was honored to present my mother’s story at the Externally Led Patient-Focused Drug Development (EL-PFDD) meeting for adult dermatomyositis, hosted by The Myositis Association and Myositis Support and Understanding. My reflections and advocacy were included in the official Voice of the Patient Report, which documents the real experiences of people and families living with dermatomyositis. I was…